13 Best Healthcare Dividend Stocks to Invest in

5. Pfizer Inc. (NYSE:PFE)

Number of Hedge Fund Holders: 92

Pfizer Inc. (NYSE:PFE) is a New York-based pharmaceutical and biotech company that specializes in a wide range of related services and products. The company reported a 12% operational revenue increase from its non-COVID products over the past year, showcasing its commitment to strategic execution. It successfully met its $4 billion net cost savings target through an ongoing cost realignment initiative and has now raised its goal to approximately $4.5 billion by the end of 2025. In addition, under its Manufacturing Optimization Program, Pfizer aims to achieve $1.5 billion in net cost savings by 2027, with the first benefits expected in the latter half of 2025. The company remains confident in its ability to restore operating margins to pre-pandemic levels in the coming years.

Pfizer Inc. (NYSE:PFE) has also focused on strengthening its presence in oncology, which was highlighted by a significant $43 billion acquisition of Seagen to enhance its cancer treatment portfolio. The company expects substantial growth in this segment over the next five years, with plans to double its patient base by 2030 and introduce at least three blockbuster drugs, each projected to generate over $1 billion in annual sales. Its progress in oncology is already evident, with revenue from this segment rising 25% in 2024.

Pfizer Inc. (NYSE:PFE), one of the best dividend stocks, offers a quarterly dividend of $0.43 per share, having raised it by 2.4% in December 2024. The stock offers an attractive dividend yield of 6.58%, as of March 20. It has been growing its payouts for 15 consecutive years.